Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)
Clinical trial NCT00152464 · COMPLETED
Trial details
- NCT number
- NCT00152464
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-20
- Primary completion
- 2006-03-15
- Enrollment
- 514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.